Want to see CI full AI Analyst Report?
CI Stock Chart & Stats
$279.32
$3.28(1.15%)
At close: 4:00 PM EDT
$279.32
$3.28(1.15%)
Day’s Range― - ―
52-Week Range$239.51 - $311.34
Previous CloseN/A
Volume1.08M
Average Volume (3M)1.53M
Market Cap
$79.88B
Enterprise Value$104.94B
Total Cash (Recent Filing)$6.30B
Total Debt (Recent Filing)$31.88B
Price to Earnings (P/E)12.5
Beta0.20
Next Earnings
Nov 05, 2026EPS Estimate
7.52Next Dividend Ex-DateN/A
Dividend Yield2.05%
Share Statistics
EPS (TTM)24.25
Shares Outstanding264,240,480
10 Day Avg. Volume1,459,515
30 Day Avg. Volume1,532,926
Financial Highlights & Ratios
PEG Ratio0.15
Price to Book (P/B)1.75
Price to Sales (P/S)0.27
P/FCF Ratio8.73
Enterprise Value/Market Cap1.31
Enterprise Value/Revenue0.37
Enterprise Value/Gross Profit3.19
Enterprise Value/Ebitda8.35
Forecast
1Y Price Target
$338.89Price Target Upside21.33% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering19
EPS Forecast (FY)30.51
Revenue Forecast (FY)$287.16B
Bulls Say, Bears Say
Bulls Say
Broad Revenue And Segment GrowthGrowth across both major platforms demonstrates broad customer demand rather than reliance on one business line. Continued expansion in health services and employer coverage can strengthen scale, support investment in capabilities, and provide a durable foundation for earnings over the next several quarters.
Strong Cash GenerationRobust operating cash generation gives Cigna internal funding for technology, modernization, debt management, and shareholder returns. High cash conversion also improves resilience when medical costs or operating conditions fluctuate, supporting financial flexibility over the medium term.
Retention And Technology AdvantagesHigh client retention supports recurring revenue, while demonstrated AI and clinical outcomes can deepen customer relationships and improve affordability. These capabilities may reinforce Cigna’s competitive position by combining data, care management, pharmacy expertise, and measurable cost savings.
Bears Say
Margin Compression And Earnings VariabilityLower and less consistent profitability reduces the amount of revenue that converts into earnings and leaves results more sensitive to operating changes. If margin pressure persists, Cigna may have less flexibility to fund growth, absorb cost increases, or deliver steady earnings progression.
Elevated Medical Cost TrendsSustained medical cost inflation can narrow the spread between premiums and claims, even when pricing and underwriting remain disciplined. Higher utilization or provider costs could therefore pressure insurance profitability and make future earnings more dependent on successful repricing and care-management actions.
PBS Transition And Margin PressureThe Signature transition creates a multi-year execution burden and is expected to keep transition expenses at similar levels in 2027. Lower PBS earnings and changing rebate economics could weigh on Evernorth margins before the intended operating benefits and productivity gains are fully realized.
CI FAQ
What was Cigna Corp’s price range in the past 12 months?
Cigna Corp lowest stock price was $239.51 and its highest was $311.34 in the past 12 months.
What is Cigna Corp’s market cap?
Cigna Corp’s market cap is $79.88B.
When is Cigna Corp’s upcoming earnings report date?
Cigna Corp’s upcoming earnings report date is Nov 05, 2026 which is in 18 days.
How were Cigna Corp’s earnings last quarter?
Cigna Corp released its earnings results on Jul 30, 2026. The company reported $7.78 earnings per share for the quarter, beating the consensus estimate of $7.596 by $0.184.
Is Cigna Corp overvalued?
According to Wall Street analysts Cigna Corp’s price is currently Undervalued.
Does Cigna Corp pay dividends?
Cigna Corp pays a Quarterly dividend of $1.56 which represents an annual dividend yield of 2.05%. See more information on Cigna Corp dividends here
What is Cigna Corp’s EPS estimate?
Cigna Corp’s EPS estimate is 7.52.
How many shares outstanding does Cigna Corp have?
Cigna Corp has 264,240,480 shares outstanding.
What happened to Cigna Corp’s price movement after its last earnings report?
Cigna Corp reported an EPS of $7.78 in its last earnings report, beating expectations of $7.596. Following the earnings report the stock price went down -2.972%.
Which hedge fund is a major shareholder of Cigna Corp?
Currently, no hedge funds are holding shares in CI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cigna Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$338.89 (21.33% Upside)
$338.89 (21.33% Upside)
Blogger Sentiment
Bullish
CI Sentiment 75%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Increased
By 1.8M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.2%
Last 30 Days ▲ 7.0%
Last 30 Days ▲ 7.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
6.21%
12-Months-Change
Fundamentals
Return on Equity
15.24%
Trailing 12-Months
Asset Growth
3.90%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Cigna Corp
Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth division offers a comprehensive array of coordinated and specialized health solutions, including pharmacy services, benefits administration, care management and delivery, and advanced intelligence solutions. These offerings cater to a diverse clientele, such as health plans, employers, government entities, and healthcare providers. Meanwhile, the Cigna Healthcare segment delivers an extensive portfolio of products and services, encompassing medical, pharmaceutical, behavioral health, dental, vision, and health advocacy programs for both insured and self-insured customers. This segment also provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans specifically for seniors, in addition to individual health insurance options available on and off public exchanges. Globally, Cigna Healthcare extends international health coverage and benefits to mobile professionals and employees of multinational organizations. Furthermore, the company issues permanent insurance contracts to corporations, designed to cover the lives of specific employees for funding future benefit obligations. Cigna distributes its various offerings through insurance brokers and consultants, direct sales channels to employers, unions, and individuals, and via both private and public exchanges.
CI Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum driven by specialty drug growth, Evernorth and Cigna Healthcare outperformance, AI-enabled clinical initiatives with measurable outcomes, solid revenue and EPS beats, and an upgraded full-year EPS outlook. Offsetting items include PBS earnings pressure from transition investments and economic shifts due to biosimilars, moderating GLP-1 utilization, persistently elevated medical cost trends, IDR-related affordability concerns, and one-time special charges. Overall, the positive drivers (revenue growth, margin gains in Specialty, upgraded guidance, retention/new-business strength, AI initiatives) materially outweigh the manageable challenges described.View all CI earnings summariesCI Stock 12 Month Forecast
Average Price Target
$338.89
▲(21.33% Upside)
Technical Analysis
Ownership Overview
0.34% Insiders
28.22% Mutual Funds
0.50% Other Institutional Investors
45.69% Public Companies and Individual Investors








